pLKO-p53-shRNA-941 Citations (11)

Originally described in: Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA.
Kim JS, Lee C, Bonifant CL, Ressom H, Waldman T Mol Cell Biol. 2007 Jan . 27(2):662-77. PubMed Journal

---

Articles Citing pLKO-p53-shRNA-941

Articles
Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1. Duan L, Perez RE, Hansen M, Gitelis S, Maki CG. Cancer Biol Ther. 2014;15(12):1600-12. doi: 10.4161/15384047.2014.961876. PubMed
Small-molecule inhibitors of USP7 induce apoptosis through oxidative and endoplasmic reticulum stress in cancer cells. Lee G, Oh TI, Um KB, Yoon H, Son J, Kim BM, Kim HI, Kim H, Kim YJ, Lee CS, Lim JH. Biochem Biophys Res Commun. 2016 Jan 29;470(1):181-6. doi: 10.1016/j.bbrc.2016.01.021. Epub 2016 Jan 6. PubMed
ATR Kinase Inhibition Protects Non-cycling Cells from the Lethal Effects of DNA Damage and Transcription Stress. Kemp MG, Sancar A. J Biol Chem. 2016 Apr 22;291(17):9330-42. doi: 10.1074/jbc.M116.719740. Epub 2016 Mar 3. PubMed
Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression. Xu WW, Li B, Guan XY, Chung SK, Wang Y, Yip YL, Law SY, Chan KT, Lee NP, Chan KW, Xu LY, Li EM, Tsao SW, He QY, Cheung AL. Nat Commun. 2017 Feb 10;8:14399. doi: 10.1038/ncomms14399. PubMed
Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response. Park DE, Cheng J, Berrios C, Montero J, Cortes-Cros M, Ferretti S, Arora R, Tillgren ML, Gokhale PC, DeCaprio JA. Proc Natl Acad Sci U S A. 2019 Jan 15;116(3):1027-1032. doi: 10.1073/pnas.1818798116. Epub 2018 Dec 31. PubMed
Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity. Aho ER, Wang J, Gogliotti RD, Howard GC, Phan J, Acharya P, Macdonald JD, Cheng K, Lorey SL, Lu B, Wenzel S, Foshage AM, Alvarado J, Wang F, Shaw JG, Zhao B, Weissmiller AM, Thomas LR, Vakoc CR, Hall MD, Hiebert SW, Liu Q, Stauffer SR, Fesik SW, Tansey WP. Cell Rep. 2019 Mar 12;26(11):2916-2928.e13. doi: 10.1016/j.celrep.2019.02.047. PubMed
WDR5 is a conserved regulator of protein synthesis gene expression. Bryan AF, Wang J, Howard GC, Guarnaccia AD, Woodley CM, Aho ER, Rellinger EJ, Matlock BK, Flaherty DK, Lorey SL, Chung DH, Fesik SW, Liu Q, Weissmiller AM, Tansey WP. Nucleic Acids Res. 2020 Apr 6;48(6):2924-2941. doi: 10.1093/nar/gkaa051. PubMed
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer. Singh N, Ramnarine VR, Song JH, Pandey R, Padi SKR, Nouri M, Olive V, Kobelev M, Okumura K, McCarthy D, Hanna MM, Mukherjee P, Sun B, Lee BR, Parker JB, Chakravarti D, Warfel NA, Zhou M, Bearss JJ, Gibb EA, Alshalalfa M, Karnes RJ, Small EJ, Aggarwal R, Feng F, Wang Y, Buttyan R, Zoubeidi A, Rubin M, Gleave M, Slack FJ, Davicioni E, Beltran H, Collins C, Kraft AS. Nat Commun. 2021 Dec 21;12(1):7349. doi: 10.1038/s41467-021-26901-9. PubMed
Synergistic action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells. Florian AC, Woodley CM, Wang J, Grieb BC, Slota MJ, Guerrazzi K, Hsu CY, Matlock BK, Flaherty DK, Lorey SL, Fesik SW, Howard GC, Liu Q, Weissmiller AM, Tansey WP. NAR Cancer. 2022 Mar 3;4(1):zcac007. doi: 10.1093/narcan/zcac007. eCollection 2022 Mar. PubMed
Impact of p53 knockdown on protein dataset of HaCaT cells. Romashin DD, Rusanov AL, Kozhin PM, Karagyaur MN, Tikhonova OV, Zgoda VG, Luzgina NG. Data Brief. 2022 May 15;42:108274. doi: 10.1016/j.dib.2022.108274. eCollection 2022 Jun. PubMed
Cancer-associated MDM2 W329G mutant attenuates ribosomal stress-mediated p53 responses to promote cell survival and glycolysis. Lien S, Whitbread TP, Shastri SO, Contreras JA, Zhao R, Zhu Y. Am J Cancer Res. 2024 May 15;14(5):2141-2156. doi: 10.62347/QIFC4021. eCollection 2024. PubMed

If you have published an article using this material, please email us at to have your article added to this page.